1.
2.
Tertiary lymphoid structures harbour stem-like tumour-specific T cells
(feeds.nature.com)
3.
4.
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk
(feeds.nature.com)
5.
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
(feeds.nature.com)